AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis
Canada - TSX:AVNT - CA05353D2023 - Common Stock
0.61 CAD
+0.01 (+1.67%)
Overall AVNT gets a fundamental rating of 2 out of 10. We evaluated AVNT against 31 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of AVNT have multiple concerns. AVNT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year AVNT has reported negative net income.
AVNT had a positive operating cash flow in the past year.
AVNT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AVNT reported negative operating cash flow in multiple years.
1.2 Ratios
AVNT has a Return On Assets of -40.53%. This is in the lower half of the industry: AVNT underperforms 75.00% of its industry peers.
With a Return On Equity value of -74.11%, AVNT is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.44%, AVNT is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.53% | ||
| ROE | -74.11% | ||
| ROIC | 1.44% |
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 1.99%, AVNT is doing good in the industry, outperforming 62.50% of the companies in the same industry.
AVNT has a Gross Margin (30.58%) which is in line with its industry peers.
AVNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.99% | ||
| PM (TTM) | N/A | ||
| GM | 30.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVNT is destroying value.
The number of shares outstanding for AVNT has been increased compared to 1 year ago.
Compared to 5 years ago, AVNT has less shares outstanding
Compared to 1 year ago, AVNT has a worse debt to assets ratio.
2.2 Solvency
AVNT has an Altman-Z score of -1.51. This is a bad value and indicates that AVNT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.51, AVNT is doing worse than 62.50% of the companies in the same industry.
AVNT has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as AVNT would need 6.46 years to pay back of all of its debts.
AVNT has a better Debt to FCF ratio (6.46) than 75.00% of its industry peers.
AVNT has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
AVNT has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: AVNT outperforms 46.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 6.46 | ||
| Altman-Z | -1.51 |
ROIC/WACC0.21
WACC6.7%
2.3 Liquidity
A Current Ratio of 1.63 indicates that AVNT should not have too much problems paying its short term obligations.
The Current ratio of AVNT (1.63) is comparable to the rest of the industry.
AVNT has a Quick Ratio of 1.63. This is a bad value and indicates that AVNT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AVNT (0.85) is worse than 71.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.63 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
AVNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.18%.
The Revenue has grown by 26.36% in the past year. This is a very strong growth!
Measured over the past years, AVNT shows a very strong growth in Revenue. The Revenue has been growing by 72.25% on average per year.
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
AVNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
AVNT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AVNT is cheaper than 96.88% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVNT indicates a rather cheap valuation: AVNT is cheaper than 96.88% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.97 | ||
| EV/EBITDA | 4.05 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
AVNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:AVNT (10/24/2025, 7:00:00 PM)
0.61
+0.01 (+1.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.34%
Ins Owner ChangeN/A
Market Cap6.96M
Revenue(TTM)37.49M
Net Income(TTM)-20024000
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.19 | ||
| P/FCF | 2.97 | ||
| P/OCF | 2.86 | ||
| P/B | 0.26 | ||
| P/tB | 0.27 | ||
| EV/EBITDA | 4.05 |
EPS(TTM)-1.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY33.65%
OCF(TTM)0.21
OCFY34.96%
SpS3.29
BVpS2.37
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.53% | ||
| ROE | -74.11% | ||
| ROCE | 2% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.48% | ||
| ROICexgc | 1.52% | ||
| OM | 1.99% | ||
| PM (TTM) | N/A | ||
| GM | 30.58% | ||
| FCFM | 6.25% |
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 6.46 | ||
| Debt/EBITDA | 1.99 | ||
| Cap/Depr | 2.04% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 46.72% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.63 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | -1.51 |
F-Score3
WACC6.7%
ROIC/WACC0.21
Cap/Depr(3y)30.6%
Cap/Depr(5y)37.88%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y778.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y156.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.1%
OCF growth 3YN/A
OCF growth 5YN/A
AVANT BRANDS INC / AVNT.CA FAQ
What is the fundamental rating for AVNT stock?
ChartMill assigns a fundamental rating of 2 / 10 to AVNT.CA.
What is the valuation status of AVANT BRANDS INC (AVNT.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to AVANT BRANDS INC (AVNT.CA). This can be considered as Overvalued.
How profitable is AVANT BRANDS INC (AVNT.CA) stock?
AVANT BRANDS INC (AVNT.CA) has a profitability rating of 2 / 10.